Skip to main content
. 2020 Feb 7;2020:4291327. doi: 10.1155/2020/4291327

Figure 3.

Figure 3

Expression of microRNA-221 (miR-221) after L-arginine treatment in atherosclerosis (AS) rat models and endothelial cells. (a) Relative expression of miR-221 and endothelial nitric oxide synthase (eNOS) in AS rat models. ∗P < 0.05 compared to the high-fat group; &P < 0.05 compared to the blank group. (b) Relative expression of miR-221 in endothelial cells. ∗P < 0.05 compared to the oxidized low-density lipoprotein-treated group (OxLDL); &P < 0.05 compared to the blank group. (c) Relative expression of eNOS in AS rat models. ∗P < 0.05 compared to the high-fat group; &P < 0.05 compared to the blank group. (d) Relative expression of eNOS in endothelial cells. ∗P < 0.05 compared to the OxLDL-treated group; &P < 0.05 compared to the blank group.